{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T05:21:41Z","timestamp":1794115301126,"version":"4.8.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s40120-023-00526-0","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T03:23:58Z","timestamp":1689823438000},"page":"1517-1532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Potential Ocular Biomarkers for Early Detection of Alzheimer\u2019s Disease and Their Roles in Artificial Intelligence Studies"],"prefix":"10.1007","volume":"12","author":[{"given":"Pareena","family":"Chaitanuwong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panisa","family":"Singhanetr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Methaphon","family":"Chainakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niracha","family":"Arjkongharn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paisan","family":"Ruamviboonsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3724-2391","authenticated-orcid":false,"given":"Andrzej","family":"Grzybowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"526_CR1","volume-title":"World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future","author":"AC-H Prince","year":"2016","unstructured":"Prince AC-H, Ma\u00eblenn G, Maria K, Martin K. World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future. London: Alzheimer\u2019s Disease International (ADI); 2016."},{"key":"526_CR2","volume-title":"World Alzheimer report 2018: the state of the art of dementia research: new frontiers","author":"C Patterson","year":"2018","unstructured":"Patterson C. World Alzheimer report 2018: the state of the art of dementia research: new frontiers. London: Alzheimer\u2019s Disease International (ADI); 2018."},{"key":"526_CR3","volume-title":"World Alzheimer report 2021: journey through the diagnosis of dementia","author":"S Gauthier","year":"2021","unstructured":"Gauthier S, Rosa-Neto P, Morais JA, Webster C. World Alzheimer report 2021: journey through the diagnosis of dementia. London: Alzheimer\u2019s Disease International (ADI); 2021."},{"key":"526_CR4","first-page":"123","volume":"9","author":"J Rasmussen","year":"2019","unstructured":"Rasmussen J, Langerman H. Alzheimer\u2019s disease\u2014why we need early diagnosis. Degener Neurol Neuromuscul Dis. 2019;9:123\u201330.","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"526_CR5","doi-asserted-by":"crossref","unstructured":"Weller J, Budson A. Current understanding of Alzheimer\u2019s disease diagnosis and treatment. F1000Res. 2018;7:F1000.","DOI":"10.12688\/f1000research.14506.1"},{"issue":"6","key":"526_CR6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/NRL.0b013e31826a998d","volume":"18","author":"AE Budson","year":"2012","unstructured":"Budson AE, Solomon PR. New criteria for Alzheimer disease and mild cognitive impairment: implications for the practicing clinician. Neurologist. 2012;18(6):356\u201363.","journal-title":"Neurologist"},{"key":"526_CR7","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100875","volume":"35","author":"L Dong","year":"2021","unstructured":"Dong L, Yang Q, Zhang RH, Wei WB. Artificial intelligence for the detection of age-related macular degeneration in color fundus photographs: a systematic review and meta-analysis. EClinicalMedicine. 2021;35:100875.","journal-title":"EClinicalMedicine"},{"issue":"2","key":"526_CR8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/ICU.0000000000000552","volume":"30","author":"C Zheng","year":"2019","unstructured":"Zheng C, Johnson TV, Garg A, Boland MV. Artificial intelligence in glaucoma. Curr Opin Ophthalmol. 2019;30(2):97\u2013103.","journal-title":"Curr Opin Ophthalmol"},{"issue":"18","key":"526_CR9","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1056\/NEJMoa1917130","volume":"382","author":"D Milea","year":"2020","unstructured":"Milea D, Najjar RP, Jiang Z, et al. Artificial intelligence to detect papilledema from ocular fundus photographs. N Engl J Med. 2020;382(18):1687\u201395.","journal-title":"N Engl J Med"},{"issue":"3","key":"526_CR10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41433-019-0566-0","volume":"34","author":"A Grzybowski","year":"2020","unstructured":"Grzybowski A, Brona P, Lim G, et al. Artificial intelligence for diabetic retinopathy screening: a review. Eye (Lond). 2020;34(3):451\u201360.","journal-title":"Eye (Lond)"},{"issue":"2","key":"526_CR11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.9.2.6","volume":"9","author":"SK Wagner","year":"2020","unstructured":"Wagner SK, Fu DJ, Faes L, et al. Insights into systemic disease through retinal imaging-based oculomics. Transl Vis Sci Technol. 2020;9(2):6.","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"526_CR12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/wps.20050","volume":"12","author":"DA Regier","year":"2013","unstructured":"Regier DA, Kuhl EA, Kupfer DJ. The DSM-5: classification and criteria changes. World Psychiatry. 2013;12(2):92\u20138.","journal-title":"World Psychiatry"},{"key":"526_CR13","first-page":"536","volume":"10","author":"JK Lim","year":"2016","unstructured":"Lim JK, Li Q-X, He Z, et al. The eye as a biomarker for Alzheimer\u2019s disease. Front Neurosci. 2016;10:536.","journal-title":"Front Neurosci"},{"issue":"10","key":"526_CR14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3390\/biomedicines8100421","volume":"8","author":"AF B\u0103la\u015fa","year":"2020","unstructured":"B\u0103la\u015fa AF, Chircov C, Grumezescu AMJB. Body fluid biomarkers for Alzheimer\u2019s disease\u2014an up-to-date overview. Biomedicines. 2020;8(10):421.","journal-title":"Biomedicines"},{"key":"526_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parkreldis.2019.03.001","volume":"63","author":"M Boerger","year":"2019","unstructured":"Boerger M, Funke S, Leha A, et al. Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson\u2019s disease\u2014a pilot study. Parkinsonism Relat Disord. 2019;63:3\u20139.","journal-title":"Parkinsonism Relat Disord"},{"issue":"3\u20134","key":"526_CR16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/prca.201300053","volume":"8","author":"C Salvisberg","year":"2014","unstructured":"Salvisberg C, Tajouri N, Hainard A, Burkhard PR, Lalive PH, Turck N. Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis. Proteom Clin Appl. 2014;8(3\u20134):185\u201394.","journal-title":"Proteom Clin Appl"},{"key":"526_CR17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2019.103403","volume":"204","author":"D Pieragostino","year":"2019","unstructured":"Pieragostino D, Lanuti P, Cicalini I, et al. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis. J Proteom. 2019;204:103403.","journal-title":"J Proteom"},{"issue":"17","key":"526_CR18","doi-asserted-by":"crossref","first-page":"10123","DOI":"10.3390\/ijms231710123","volume":"23","author":"A Kr\u00f3l-Grzyma\u0142a","year":"2022","unstructured":"Kr\u00f3l-Grzyma\u0142a A, Sienkiewicz-Sz\u0142apka E, Fiedorowicz E, Rozmus D, Cie\u015bli\u0144ska A, Grzybowski A. Tear biomarkers in Alzheimer\u2019s and Parkinson\u2019s diseases, and multiple sclerosis: implications for diagnosis (systematic review). Int J Mol Sci. 2022;23(17):10123.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"526_CR19","volume":"11","author":"G Kall\u00f3","year":"2016","unstructured":"Kall\u00f3 G, Emri M, Varga Z, et al. Changes in the chemical barrier composition of tears in Alzheimer\u2019s disease reveal potential tear diagnostic biomarkers. PLoS\u00a0One. 2016;11(6):e0158000.","journal-title":"PLoS\u00a0One"},{"issue":"9","key":"526_CR20","first-page":"1744","volume":"60","author":"M Gijs","year":"2019","unstructured":"Gijs M, Nuijts RM, Ramakers I, Verhey F, Webers CA. Differences in tear protein biomarkers between patients with Alzheimer\u2019s disease and controls. Invest Ophthalmol Vis Sci. 2019;60(9):1744.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"22","key":"526_CR21","doi-asserted-by":"crossref","first-page":"8099","DOI":"10.1021\/acs.analchem.0c04980","volume":"93","author":"Y-R Wang","year":"2021","unstructured":"Wang Y-R, Chuang H-C, Tripathi A, et al. High-sensitivity and trace-amount specimen electrochemical sensors for exploring the levels of \u03b2-amyloid in human blood and tears. Anal Chem. 2021;93(22):8099\u2013106.","journal-title":"Anal Chem"},{"issue":"2","key":"526_CR22","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/jsfa.10684","volume":"101","author":"X Wang","year":"2021","unstructured":"Wang X, Yu Z, Zhao X, et al. Comparative proteomic characterization of bovine milk containing \u03b2-casein variants A1A1 and A2A2, and their heterozygote A1A2. J Sci Food Agric. 2021;101(2):718\u201325.","journal-title":"J Sci Food Agric"},{"issue":"1","key":"526_CR23","doi-asserted-by":"crossref","first-page":"22675","DOI":"10.1038\/s41598-021-01993-x","volume":"11","author":"M Gijs","year":"2021","unstructured":"Gijs M, Ramakers IHGB, Visser PJ, et al. Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration. Sci Rep. 2021;11(1):22675.","journal-title":"Sci Rep"},{"key":"526_CR24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fphys.2015.00040","volume":"6","author":"GD Femminella","year":"2015","unstructured":"Femminella GD, Ferrara N, Rengo G. The emerging role of microRNAs in Alzheimer\u2019s disease. Front Physiol. 2015;6:40.","journal-title":"Front Physiol"},{"issue":"1","key":"526_CR25","doi-asserted-by":"crossref","first-page":"15437","DOI":"10.1038\/s41598-019-51837-y","volume":"9","author":"A Kenny","year":"2019","unstructured":"Kenny A, Jim\u00e9nez-Mateos EM, Zea-Sevilla MA, et al. Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer\u2019s disease. Sci Rep. 2019;9(1):15437.","journal-title":"Sci Rep"},{"issue":"4","key":"526_CR26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/02713683.2014.930154","volume":"40","author":"N \u00d6rnek","year":"2015","unstructured":"\u00d6rnek N, Da\u011f E, \u00d6rnek K. Corneal sensitivity and tear function in neurodegenerative diseases. Curr Eye Res. 2015;40(4):423\u20138.","journal-title":"Curr Eye Res"},{"issue":"4","key":"526_CR27","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/acn3.746","volume":"6","author":"G Ponirakis","year":"2019","unstructured":"Ponirakis G, Al Hamad H, Sankaranarayanan A, et al. Association of corneal nerve fiber measures with cognitive function in dementia. Ann Clin Transl Neurol. 2019;6(4):689\u201397.","journal-title":"Ann Clin Transl Neurol"},{"issue":"4","key":"526_CR28","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3233\/JAD-200678","volume":"77","author":"E Al-Janahi","year":"2020","unstructured":"Al-Janahi E, Ponirakis G, Al Hamad H, et al. Corneal nerve and brain imaging in mild cognitive impairment and dementia. J Alzheimers Dis. 2020;77(4):1533\u201343.","journal-title":"J Alzheimers Dis"},{"key":"526_CR29","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.556137","volume":"14","author":"C Dehghani","year":"2020","unstructured":"Dehghani C, Frost S, Jayasena R, et al. Morphometric changes to corneal dendritic cells in individuals with mild cognitive impairment. Front Neurosci. 2020;14:556137.","journal-title":"Front Neurosci"},{"key":"526_CR30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/bs.irn.2015.08.002","volume":"124","author":"J Shen","year":"2015","unstructured":"Shen J, Wu J. Nicotinic cholinergic mechanisms in Alzheimer\u2019s disease. Int Rev Neurobiol. 2015;124:275\u201392.","journal-title":"Int Rev Neurobiol"},{"issue":"4","key":"526_CR31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4103\/ijo.IJO_999_19","volume":"68","author":"AK Singh","year":"2020","unstructured":"Singh AK, Verma S. Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer\u2019s disease. Indian J Ophthalmol. 2020;68(4):555\u201361.","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"526_CR32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpsycho.2009.01.011","volume":"73","author":"D Fotiou","year":"2009","unstructured":"Fotiou D, Stergiou V, Tsiptsios D, Lithari C, Nakou M, Karlovasitou A. Cholinergic deficiency in Alzheimer\u2019s and Parkinson\u2019s disease: evaluation with pupillometry. Int J Psychophysiol. 2009;73(2):143\u20139.","journal-title":"Int J Psychophysiol"},{"issue":"8","key":"526_CR33","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2174\/15672050113109990154","volume":"10","author":"SM Frost","year":"2013","unstructured":"Frost SM, Kanagasingam Y, Sohrabi HR, et al. Pupil response biomarkers distinguish amyloid precursor protein mutation carriers from non-carriers. Curr Alzheimer Res. 2013;10(8):790\u20136.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"526_CR34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bpa.12070","volume":"24","author":"CY Ho","year":"2014","unstructured":"Ho CY, Troncoso JC, Knox D, Stark W, Eberhart CG. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer\u2019s and Parkinson\u2019s disease patients. Brain Pathol. 2014;24(1):25\u201332.","journal-title":"Brain Pathol"},{"issue":"5","key":"526_CR35","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jnen\/nlx020","volume":"76","author":"EA Williams","year":"2017","unstructured":"Williams EA, McGuone D, Frosch MP, Hyman BT, Laver N, Stemmer-Rachamimov A. Absence of Alzheimer disease neuropathologic changes in eyes of subjects with Alzheimer disease. J Neuropathol Exp Neurol. 2017;76(5):376\u201383.","journal-title":"J Neuropathol Exp Neurol"},{"key":"526_CR36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.exer.2012.10.012","volume":"106","author":"R Michael","year":"2013","unstructured":"Michael R, Rosandi\u0107 J, Montenegro GA, et al. Absence of beta-amyloid in cortical cataracts of donors with and without Alzheimer\u2019s disease. Exp Eye Res. 2013;106:5\u201313.","journal-title":"Exp Eye Res"},{"issue":"8","key":"526_CR37","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1167\/iovs.18-24694","volume":"59","author":"C Dehghani","year":"2018","unstructured":"Dehghani C, Frost S, Jayasena R, Masters CL, Kanagasingam Y. Ocular biomarkers of Alzheimer\u2019s disease: the role of anterior eye and potential future directions. Investig Ophthalmol Vis Sci. 2018;59(8):3554\u201363.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"526_CR38","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, et al. Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage. 2011;54:S204\u201317.","journal-title":"Neuroimage"},{"key":"526_CR39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3389\/fneur.2017.00701","volume":"8","author":"J Doustar","year":"2017","unstructured":"Doustar J, Torbati T, Black KL, Koronyo Y, Koronyo-Hamaoui M. Optical coherence tomography in Alzheimer\u2019s disease and other neurodegenerative diseases. Front Neurol. 2017;8:701.","journal-title":"Front Neurol"},{"key":"526_CR40","doi-asserted-by":"crossref","unstructured":"Campbell MC, Vries DD, Emptage L, et al. Polarization properties of amyloid beta in the retina of the eye as a biomarker of Alzheimer\u2019s disease. Bio-Optics: design and application. Optica Publishing Group. 2015;BM3A:4.","DOI":"10.1364\/BODA.2015.BM3A.4"},{"issue":"1","key":"526_CR41","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1038\/s41467-019-12242-1","volume":"10","author":"X Hadoux","year":"2019","unstructured":"Hadoux X, Hui F, Lim JKH, et al. Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer\u2019s disease. Nat Commun. 2019;10(1):4227.","journal-title":"Nat Commun"},{"issue":"12","key":"526_CR42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosc. 2011;12(12):723\u201338.","journal-title":"Nat Rev Neurosc"},{"issue":"1","key":"526_CR43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/alz.12006","volume":"16","author":"J Alber","year":"2020","unstructured":"Alber J, Goldfarb D, Thompson LI, et al. Developing retinal biomarkers for the earliest stages of Alzheimer\u2019s disease: what we know, what we don\u2019t, and how to move forward. Alzheimers Dement. 2020;16(1):229\u201343.","journal-title":"Alzheimers Dement"},{"key":"526_CR44","volume":"69","author":"Y-J Ge","year":"2021","unstructured":"Ge Y-J, Xu W, Ou Y-N, et al. Retinal biomarkers in Alzheimer\u2019s disease and mild cognitive impairment: a systematic review and meta-analysis. Ageing Res Rev. 2021;69: 101361.","journal-title":"Ageing Res Rev"},{"key":"526_CR45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fnins.2020.00016","volume":"14","author":"S Lemmens","year":"2020","unstructured":"Lemmens S, Devulder A, Van Keer K, Bierkens J, De Boever P, Stalmans I. Systematic review on fractal dimension of the retinal vasculature in neurodegeneration and stroke: assessment of a potential biomarker. Front Neurosci. 2020;14:16.","journal-title":"Front Neurosci"},{"issue":"1","key":"526_CR46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3988\/jcn.2020.16.1.19","volume":"16","author":"H Wu","year":"2020","unstructured":"Wu H, Wang C, Chen C, et al. Association between retinal vascular geometric changes and cognitive impairment: a systematic review and meta-analysis. J Clin Neurol. 2020;16(1):19\u201328.","journal-title":"J Clin Neurol"},{"key":"526_CR47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.dadm.2016.11.001","volume":"6","author":"S McGrory","year":"2017","unstructured":"McGrory S, Cameron JR, Pellegrini E, et al. The application of retinal fundus camera imaging in dementia: a systematic review. Alzheimers Dement (Amst). 2017;6:91\u2013107.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"4","key":"526_CR48","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ophtha.2018.08.009","volume":"126","author":"VTT Chan","year":"2019","unstructured":"Chan VTT, Sun Z, Tang S, et al. Spectral-domain OCT measurements in Alzheimer\u2019s disease: a systematic review and meta-analysis. Ophthalmology. 2019;126(4):497\u2013510.","journal-title":"Ophthalmology"},{"issue":"4","key":"526_CR49","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/08820538.2017.1332233","volume":"33","author":"PP Chhablani","year":"2018","unstructured":"Chhablani PP, Ambiya V, Nair AG, Bondalapati S, Chhablani J. Retinal findings on OCT in systemic conditions. Semin Ophthalmol. 2018;33(4):525\u201346.","journal-title":"Semin Ophthalmol"},{"key":"526_CR50","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.dadm.2016.12.014","volume":"6","author":"J den Haan","year":"2017","unstructured":"den Haan J, Verbraak FD, Visser PJ, Bouwman FH. Retinal thickness in Alzheimer\u2019s disease: a systematic review and meta-analysis. Alzheimers Dement (Amst). 2017;6:162\u201370.","journal-title":"Alzheimers Dement (Amst)"},{"key":"526_CR51","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.dadm.2016.07.004","volume":"4","author":"B Knoll","year":"2016","unstructured":"Knoll B, Simonett J, Volpe NJ, et al. Retinal nerve fiber layer thickness in amnestic mild cognitive impairment: case-control study and meta-analysis. Alzheimers Dement (Amst). 2016;4:85\u201393.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"10","key":"526_CR52","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3390\/medicina56100553","volume":"56","author":"A L\u00f3pez-de-Eguileta","year":"2020","unstructured":"L\u00f3pez-de-Eguileta A, Cerver\u00f3 A, de Sabando AR, S\u00e1nchez-Juan P, Casado A. Ganglion cell layer thinning in Alzheimer\u2019s disease. Medicina (Kaunas). 2020;56(10):553.","journal-title":"Medicina (Kaunas)"},{"key":"526_CR53","volume":"11","author":"AJ Mejia-Vergara","year":"2020","unstructured":"Mejia-Vergara AJ, Restrepo-Jimenez P, Pelak VS. Optical coherence tomography in mild cognitive impairment: a systematic review and meta-analysis. Front Neurol. 2020;11: 578698.","journal-title":"Front Neurol"},{"key":"526_CR54","volume":"196","author":"AM Noah","year":"2020","unstructured":"Noah AM, Almghairbi D, Moppett IK. Optical coherence tomography in mild cognitive impairment\u2014systematic review and meta-analysis. Clin Neurol Neurosurg. 2020;196: 106036.","journal-title":"Clin Neurol Neurosurg"},{"issue":"8","key":"526_CR55","volume":"16","author":"J Hui","year":"2021","unstructured":"Hui J, Zhao Y, Yu S, Liu J, Chiu K, Wang Y. Detection of retinal changes with optical coherence tomography angiography in mild cognitive impairment and Alzheimer\u2019s disease patients: a meta-analysis. PLoS\u00a0One. 2021;16(8): e0255362.","journal-title":"PLoS\u00a0One"},{"key":"526_CR56","volume":"13","author":"Q Jin","year":"2021","unstructured":"Jin Q, Lei Y, Wang R, Wu H, Ji K, Ling L. A systematic review and meta-analysis of retinal microvascular features in Alzheimer\u2019s disease. Front Aging Neurosci. 2021;13: 683824.","journal-title":"Front Aging Neurosci"},{"issue":"7","key":"526_CR57","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/s41433-021-01648-1","volume":"36","author":"A Katsimpris","year":"2022","unstructured":"Katsimpris A, Karamaounas A, Sideri AM, Katsimpris J, Georgalas I, Petrou P. Optical coherence tomography angiography in Alzheimer\u2019s disease: a systematic review and meta-analysis. Eye (Lond). 2022;36(7):1419\u201326.","journal-title":"Eye (Lond)"},{"issue":"1","key":"526_CR58","volume":"13","author":"OM Rifai","year":"2021","unstructured":"Rifai OM, McGrory S, Robbins CB, et al. The application of optical coherence tomography angiography in Alzheimer\u2019s disease: a systematic review. Alzheimers Dement (Amst). 2021;13(1): e12149.","journal-title":"Alzheimers Dement (Amst)"},{"key":"526_CR59","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3389\/fneur.2020.01009","volume":"11","author":"J-F Zhang","year":"2020","unstructured":"Zhang J-F, Wiseman S, Vald\u00e9s-Hern\u00e1ndez MC, et al. The application of optical coherence tomography angiography in cerebral small vessel disease, ischemic stroke, and dementia: a systematic review. Front Neurol. 2020;11:1009.","journal-title":"Front Neurol"},{"issue":"7","key":"526_CR60","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/jcm8070996","volume":"8","author":"D Cabrera DeBuc","year":"2019","unstructured":"Cabrera DeBuc D, Gaca-Wysocka M, Grzybowski A, Kanclerz P. Identification of retinal biomarkers in Alzheimer\u2019s disease using optical coherence tomography: recent insights, challenges, and opportunities. J Clin Med. 2019;8(7):996.","journal-title":"J Clin Med"},{"key":"526_CR61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.dadm.2016.09.001","volume":"4","author":"PJ Snyder","year":"2016","unstructured":"Snyder PJ, Johnson LN, Lim YY, et al. Nonvascular retinal imaging markers of preclinical Alzheimer\u2019s disease. Alzheimers Dement (Amst). 2016;4:169\u201378.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"526_CR62","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jamaophthalmol.2022.4845","volume":"141","author":"E Costanzo","year":"2023","unstructured":"Costanzo E, Lengyel I, Parravano M, et al. Ocular biomarkers for Alzheimer disease dementia: an umbrella review of systematic reviews and meta-analyses. JAMA Ophthalmol. 2023;141(1):84\u201391.","journal-title":"JAMA Ophthalmol"},{"key":"526_CR63","volume":"14","author":"T-C Yeh","year":"2022","unstructured":"Yeh T-C, Kuo C-T, Chou Y-B. Retinal microvascular changes in mild cognitive impairment and Alzheimer\u2019s disease: a systematic review, meta-analysis, and meta-regression. Front Aging Neurosci. 2022;14: 860759.","journal-title":"Front Aging Neurosci"},{"key":"526_CR64","doi-asserted-by":"crossref","first-page":"S411","DOI":"10.3233\/JAD-141467","volume":"42","author":"CE Wierenga","year":"2014","unstructured":"Wierenga CE, Hays CC, Zlatar ZZ. Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer\u2019s disease. J Alzheimers Dis. 2014;42:S411\u20139.","journal-title":"J Alzheimers Dis"},{"key":"526_CR65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3233\/JAD-220482","volume":"90","author":"X Wang","year":"2022","unstructured":"Wang X, Wang Y, Liu H, et al. Macular microvascular density as a diagnostic biomarker for Alzheimer\u2019s disease. J Alzheimers Dis. 2022;90:139\u201349.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"526_CR66","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/eye.2017.23","volume":"31","author":"V Polo","year":"2017","unstructured":"Polo V, Rodrigo MJ, Garcia-Martin E, et al. Visual dysfunction and its correlation with retinal changes in patients with Alzheimer\u2019s disease. Eye (Lond). 2017;31(7):1034\u201341.","journal-title":"Eye (Lond)"},{"key":"526_CR67","doi-asserted-by":"crossref","first-page":"8538573","DOI":"10.1155\/2018\/8538573","volume":"2018","author":"P Colligris","year":"2018","unstructured":"Colligris P, de Lara MJP, Colligris B, Pintor J. Ocular manifestations of Alzheimer\u2019s and other neurodegenerative diseases: the prospect of the eye as a tool for the early diagnosis of Alzheimer\u2019s disease. J Ophthalmol. 2018;2018:8538573.","journal-title":"J Ophthalmol"},{"issue":"8","key":"526_CR68","volume":"14","author":"E Salobrar-Garc\u00eda","year":"2019","unstructured":"Salobrar-Garc\u00eda E, de Hoz R, Ram\u00edrez AI, et al. Changes in visual function and retinal structure in the progression of Alzheimer\u2019s disease. PLoS\u00a0One. 2019;14(8):e0220535.","journal-title":"PLoS\u00a0One"},{"issue":"11","key":"526_CR69","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1093\/gerona\/glaa036","volume":"75","author":"ATC Lee","year":"2020","unstructured":"Lee ATC, Richards M, Chan WC, Chiu HFK, Lee RSY, Lam LCW. Higher dementia incidence in older adults with poor visual acuity. J Gerontol A Biol Sci Med Sci. 2020;75(11):2162\u20138.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"526_CR70","volume":"10","author":"C-N Lee","year":"2015","unstructured":"Lee C-N, Ko D, Suh Y-W, Park K-W. Cognitive functions and stereopsis in patients with Parkinson\u2019s disease and Alzheimer\u2019s disease using 3-dimensional television: a case controlled trial. PLoS\u00a0One. 2015;10(3):e0123229.","journal-title":"PLoS\u00a0One"},{"issue":"2","key":"526_CR71","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/healthcare9020157","volume":"9","author":"N-G Kim","year":"2021","unstructured":"Kim N-G, Lee H-W. Stereoscopic depth perception and visuospatial dysfunction in Alzheimer\u2019s disease. Healthcare (Basel). 2021;9(2):157.","journal-title":"Healthcare (Basel)"},{"key":"526_CR72","unstructured":"Binder MD, Hirokawa N, Windhorst U (eds). Encyclopedia of neuroscience. Saccadic eye movement. Springer, Berlin, p. 3564."},{"issue":"7","key":"526_CR73","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0028-3932(00)00155-X","volume":"39","author":"A Broerse","year":"2001","unstructured":"Broerse A, Crawford TJ, den Boer JA. Parsing cognition in schizophrenia using saccadic eye movements: a selective overview. Neuropsychologia. 2001;39(7):742\u201356.","journal-title":"Neuropsychologia"},{"key":"526_CR74","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3389\/fpsyg.2013.00749","volume":"4","author":"SD Jamadar","year":"2013","unstructured":"Jamadar SD, Fielding J, Egan GF. Quantitative meta-analysis of fMRI and PET studies reveals consistent activation in fronto-striatal-parietal regions and cerebellum during antisaccades and prosaccades. Front Psychol. 2013;4:749.","journal-title":"Front Psychol"},{"issue":"3","key":"526_CR75","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bandc.2008.08.016","volume":"68","author":"JE McDowell","year":"2008","unstructured":"McDowell JE, Dyckman KA, Austin BP, Clementz BA. Neurophysiology and neuroanatomy of reflexive and volitional saccades: evidence from studies of humans. Brain Cogn. 2008;68(3):255\u201370.","journal-title":"Brain Cogn"},{"issue":"5","key":"526_CR76","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1080\/13607863.2021.1913471","volume":"26","author":"N Chehrehnegar","year":"2022","unstructured":"Chehrehnegar N, Shati M, Esmaeili M, Foroughan M. Executive function deficits in mild cognitive impairment: evidence from saccade tasks. Aging Ment Health. 2022;26(5):1001\u20139.","journal-title":"Aging Ment Health"},{"key":"526_CR77","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3389\/fpsyg.2013.00467","volume":"4","author":"KK Alichniewicz","year":"2013","unstructured":"Alichniewicz KK, Brunner F, Kl\u00fcnemann HH, Greenlee MW. Neural correlates of saccadic inhibition in healthy elderly and patients with amnestic mild cognitive impairment. Front Psychol. 2013;4:467.","journal-title":"Front Psychol"},{"issue":"2","key":"526_CR78","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11065-021-09495-3","volume":"32","author":"J Opwonya","year":"2022","unstructured":"Opwonya J, Doan DNT, Kim SG, et al. Saccadic eye movement in mild cognitive impairment and Alzheimer\u2019s disease: a systematic review and meta-analysis. Neuropsychol Rev. 2022;32(2):193\u2013227.","journal-title":"Neuropsychol Rev"},{"issue":"22","key":"526_CR79","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.3390\/s22228887","volume":"22","author":"B Wang","year":"2022","unstructured":"Wang B, Lim JS. Zoom-in neural network deep-learning model for Alzheimer\u2019s disease assessments. Sensors (Basel). 2022;22(22):8887.","journal-title":"Sensors (Basel)"},{"issue":"1","key":"526_CR80","doi-asserted-by":"crossref","first-page":"17106","DOI":"10.1038\/s41598-022-20674-x","volume":"12","author":"S Liu","year":"2022","unstructured":"Liu S, Masurkar AV, Rusinek H, et al. Generalizable deep learning model for early Alzheimer\u2019s disease detection from structural MRIs. Sci Rep. 2022;12(1):17106.","journal-title":"Sci Rep"},{"issue":"1","key":"526_CR81","doi-asserted-by":"crossref","first-page":"20254","DOI":"10.1038\/s41598-022-24541-7","volume":"12","author":"C Tinauer","year":"2022","unstructured":"Tinauer C, Heber S, Pirpamer L, et al. Interpretable brain disease classification and relevance-guided deep learning. Sci Rep. 2022;12(1):20254.","journal-title":"Sci Rep"},{"issue":"7","key":"526_CR82","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/00207454.2020.1835900","volume":"132","author":"TA Tuan","year":"2022","unstructured":"Tuan TA, Pham TB, Kim JY, Tavares J. Alzheimer\u2019s diagnosis using deep learning in segmenting and classifying 3D brain MR images. Int J Neurosci. 2022;132(7):689\u201398.","journal-title":"Int J Neurosci"},{"issue":"1","key":"526_CR83","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13195-022-00985-x","volume":"14","author":"X Feng","year":"2022","unstructured":"Feng X, Provenzano FA, Small SA. A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer\u2019s disease. Alzheimers Res Ther. 2022;14(1):45.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"526_CR84","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s13246-022-01165-9","volume":"45","author":"L Houria","year":"2022","unstructured":"Houria L, Belkhamsa N, Cherfa A, Cherfa Y. Multi-modality MRI for Alzheimer\u2019s disease detection using deep learning. Phys Eng Sci Med. 2022;45(4):1043\u201353.","journal-title":"Phys Eng Sci Med"},{"issue":"1","key":"526_CR85","doi-asserted-by":"crossref","first-page":"18007","DOI":"10.1038\/s41598-022-22917-3","volume":"12","author":"JS Kim","year":"2022","unstructured":"Kim JS, Han JW, Bae JB, et al. Deep learning-based diagnosis of Alzheimer\u2019s disease using brain magnetic resonance images: an empirical study. Sci Rep. 2022;12(1):18007.","journal-title":"Sci Rep"},{"key":"526_CR86","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.105032","volume":"141","author":"A Loddo","year":"2022","unstructured":"Loddo A, Buttau S, Di Ruberto C. Deep learning based pipelines for Alzheimer\u2019s disease diagnosis: a comparative study and a novel deep-ensemble method. Comput Biol Med. 2022;141: 105032.","journal-title":"Comput Biol Med"},{"key":"526_CR87","volume":"782","author":"Y Hu","year":"2022","unstructured":"Hu Y, Wen C, Cao G, Wang J, Feng Y. Brain network connectivity feature extraction using deep learning for Alzheimer\u2019s disease classification. Neurosci Lett. 2022;782: 136673.","journal-title":"Neurosci Lett"},{"issue":"8","key":"526_CR88","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.3390\/s22082911","volume":"22","author":"D AlSaeed","year":"2022","unstructured":"AlSaeed D, Omar SF. Brain MRI analysis for Alzheimer\u2019s disease diagnosis using CNN-based feature extraction and machine learning. Sensors (Basel). 2022;22(8):2911.","journal-title":"Sensors (Basel)"},{"issue":"10","key":"526_CR89","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1002\/hbm.25850","volume":"43","author":"P Coup\u00e9","year":"2022","unstructured":"Coup\u00e9 P, Manj\u00f3n JV, Mansencal B, Tourdias T, Catheline G, Planche V. Hippocampal-amygdalo-ventricular atrophy score: Alzheimer disease detection using normative and pathological lifespan models. Hum Brain Mapp. 2022;43(10):3270\u201382.","journal-title":"Hum Brain Mapp"},{"key":"526_CR90","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2022.107191","volume":"227","author":"S Tomassini","year":"2022","unstructured":"Tomassini S, Sbrollini A, Covella G, et al. Brain-on-Cloud for automatic diagnosis of Alzheimer\u2019s disease from 3D structural magnetic resonance whole-brain scans. Comput Methods Programs Biomed. 2022;227:107191.","journal-title":"Comput Methods Programs Biomed"},{"issue":"2","key":"526_CR91","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00259-021-05483-0","volume":"49","author":"K Etminani","year":"2022","unstructured":"Etminani K, Soliman A, Davidsson A, et al. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer\u2019s disease, and mild cognitive impairment using brain 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2022;49(2):563\u201384.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"526_CR92","doi-asserted-by":"crossref","first-page":"bbac022","DOI":"10.1093\/bib\/bbac022","volume":"23","author":"T Jo","year":"2022","unstructured":"Jo T, Nho K, Bice P, Saykin AJ. Deep learning-based identification of genetic variants: application to Alzheimer\u2019s disease classification. Brief Bioinform. 2022;23(2):bbac022.","journal-title":"Brief Bioinform"},{"issue":"9","key":"526_CR93","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.3390\/ijms23095237","volume":"23","author":"L Chiricosta","year":"2022","unstructured":"Chiricosta L, D\u2019Angiolini S, Gugliandolo A, Mazzon E. Artificial intelligence predictor for Alzheimer\u2019s disease trained on blood transcriptome: the role of oxidative stress. Int J Mol Sci. 2022;23(9):5237.","journal-title":"Int J Mol Sci"},{"key":"526_CR94","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.105056","volume":"141","author":"N Mahendran","year":"2022","unstructured":"Mahendran N, Durai Raj VPM. A deep learning framework with an embedded-based feature selection approach for the early detection of the Alzheimer\u2019s disease. Comput Biol Med. 2022;141: 105056.","journal-title":"Comput Biol Med"},{"issue":"11","key":"526_CR95","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3390\/cells11111744","volume":"11","author":"RO Bahado-Singh","year":"2022","unstructured":"Bahado-Singh RO, Radhakrishna U, Gordevi\u010dius J, et al. Artificial intelligence and circulating cell-free DNA methylation profiling: mechanism and detection of Alzheimer\u2019s disease. Cells. 2022;11(11):1744.","journal-title":"Cells"},{"issue":"1","key":"526_CR96","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12759","volume":"48","author":"S Koga","year":"2022","unstructured":"Koga S, Ikeda A, Dickson DW. Deep learning-based model for diagnosing Alzheimer\u2019s disease and tauopathies. Neuropathol Appl Neurobiol. 2022;48(1):e12759.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"526_CR97","doi-asserted-by":"crossref","DOI":"10.1016\/j.compmedimag.2022.102074","volume":"99","author":"A Kherchouche","year":"2022","unstructured":"Kherchouche A, Ben-Ahmed O, Guillevin C, et al. Attention-guided neural network for early dementia detection using MRS data. Comput Med Imaging Graph. 2022;99:102074.","journal-title":"Comput Med Imaging Graph"},{"issue":"1","key":"526_CR98","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1038\/s41467-022-31037-5","volume":"13","author":"S Qiu","year":"2022","unstructured":"Qiu S, Miller MI, Joshi PS, et al. Multimodal deep learning for Alzheimer\u2019s disease dementia assessment. Nat Commun. 2022;13(1):3404.","journal-title":"Nat Commun"},{"issue":"12","key":"526_CR99","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/jamia\/ocac168","volume":"29","author":"M Golovanevsky","year":"2022","unstructured":"Golovanevsky M, Eickhoff C, Singh R. Multimodal attention-based deep learning for Alzheimer\u2019s disease diagnosis. J Am Med Inform Assoc. 2022;29(12):2014\u201322.","journal-title":"J Am Med Inform Assoc"},{"key":"526_CR100","volume":"148","author":"Y Tu","year":"2022","unstructured":"Tu Y, Lin S, Qiao J, Zhuang Y, Zhang P. Alzheimer\u2019s disease diagnosis via multimodal feature fusion. Comput Biol Med. 2022;148:105901.","journal-title":"Comput Biol Med"},{"issue":"3","key":"526_CR101","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/bjophthalmol-2020-317659","volume":"106","author":"CE Wisely","year":"2022","unstructured":"Wisely CE, Wang D, Henao R, et al. Convolutional neural network to identify symptomatic Alzheimer\u2019s disease using multimodal retinal imaging. Br J Ophthalmol. 2022;106(3):388\u201395.","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"526_CR102","doi-asserted-by":"crossref","first-page":"e806","DOI":"10.1016\/S2589-7500(22)00169-8","volume":"4","author":"CY Cheung","year":"2022","unstructured":"Cheung CY, Ran AR, Wang S, et al. A deep learning model for detection of Alzheimer\u2019s disease based on retinal photographs: a retrospective, multicentre case-control study. Lancet Digit Health. 2022;4(11):e806\u201315.","journal-title":"Lancet Digit Health"},{"issue":"1","key":"526_CR103","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1038\/s41598-022-09719-3","volume":"12","author":"D Corbin","year":"2022","unstructured":"Corbin D, Lesage F. Assessment of the predictive potential of cognitive scores from retinal images and retinal fundus metadata via deep learning using the CLSA database. Sci Rep. 2022;12(1):5767.","journal-title":"Sci Rep"},{"issue":"6","key":"526_CR104","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00005072-199806000-00010","volume":"57","author":"JQ Trojanowski","year":"1998","unstructured":"Trojanowski JQ, Growdon JH. A new consensus report on biomarkers for the early antemortem diagnosis of Alzheimer disease: current status, relevance to drug discovery, and recommendations for future research. J Neuropathol Exp Neurol. 1998;57(6):643\u20134.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"526_CR105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10571-015-0261-z","volume":"36","author":"CC Hays","year":"2016","unstructured":"Hays CC, Zlatar ZZ, Wierenga CE. The utility of cerebral blood flow as a biomarker of preclinical Alzheimer\u2019s disease. Cell Mol Neurobiol. 2016;36(2):167\u201379.","journal-title":"Cell Mol Neurobiol"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-023-00526-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-023-00526-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-023-00526-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T16:18:14Z","timestamp":1692721094000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-023-00526-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":105,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["526"],"URL":"https:\/\/doi.org\/10.1007\/s40120-023-00526-0","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"assertion":[{"value":"6 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding or sponsorship was received for this study or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Pareena Chaitanuwong, Paisan Ruamviboonsuk and Andrzej Grzybowski contributed to the study conception and design. Material preparation, data collection and analysis were performed by Pareena Chaitanuwong, Methaphon Chainakul and Niracha Arjkongharn. The first draft of the manuscript was written by Pareena Chaitanuwong, Panisa Singhanetr, Methaphon Chainakul and Paisan Ruamviboonsuk. All authors commented on every version of the manuscript. All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"All authors declare that they have no competing interests. Pareena Chaitanuwong, Panisa Singhanetr, Methaphon Chainakul and Niracha Arjkongharn have nothing to disclose. Paisan Ruamviboonsuk has received grants from Roche; is a consultant for Roche; and has received speaker fees from Novartis, Roche, Bayer, and Topcon. Andrzej Grzybowski has received grants from Alcon, Bausch&Lomb, Zeiss, Teleon, J&J, CooperVision and Hoya; has received lecture fees from Thea, Polpharma and Viatris; and is a member of the advisory boards of Nevakar, GoCheckKids, and Thea.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. No specific ethical approval was required for this article<b>.<\/b>","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"Data sharing is not applicable to this article as no data sets were generated or analyzed during the current study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}